相关实验视频

Updated: Jun 8, 2025

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
05:40

The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans

Published on: April 28, 2022

3.0K

促进基于医院的随机临床试验中的种族和民族多样性,以解决未经治疗的酒精使用障碍:初步经验教训

E Jennifer Edelman1, Tami Frankforter, Oscar F Rojas-Perez

  • 1From the Department of Internal Medicine, Yale School of Medicine, New Haven, CT (EJE, KA, DP, MBW); Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT (EJE, MBW, BDK); Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT (EJE); Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT (EJE, CC, IG); Department of Psychiatry, Yale School of Medicine, New Haven, CT (TF, OFR-P, JC, DMG, YJ, CN, MP, BDK); The Consultation Center, New Haven, CT (DMG); Grayken Center for Addiction at Boston Medical Center (NLJ), Boston, MA; Section of General Internal Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA (NLJ); Department of Psychiatry, NYU Langone Health, New York, NY (AJ); Hispanic Clinic, Connecticut Mental Health Center, New Haven, CT (MP); Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT (MBW); Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA (ECW); and Health Services Research and Development Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Health Administration, Seattle, WA (ECW).

Journal of addiction medicine
|November 8, 2024
PubMed
概括

招募各种酒精使用障碍 (AUD) 患者需要有意的策略. 医院试验中的多层次实践可以成功地提高种族和种族多样化的个体的招聘和保留.

更多相关视频

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

18.7K
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

7.9K

相关概念视频

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91